Skip to main content

Clinical Trials Search at Vanderbilt-Ingram Cancer Center

Study of Sacituzumab Govitecan in Participants With Urothelial Cancer That Cannot Be Removed or Has Spread

Multiple Cancer Types

The objective of this study is to evaluate the efficacy and safety of sacituzumab
govitecan-hziy monotherapy and with novel combinations in participants with metastatic
urothelial cancer (mUC).
Bladder, Urologic
Davis, Nancy

To learn more about any of our clinical
trials, call 615-936-8422.